CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
IsoPlexis Corp | February 14, 2023 | 4,095,498 | 10.0% |
IVERIC bio, Inc. | February 14, 2023 | 587,400 | 0.4% |
LEAP THERAPEUTICS, INC. | February 14, 2023 | 6,726,496 | 6.8% |
Mirati Therapeutics, Inc. | February 14, 2023 | 2,191,425 | 3.8% |
Neptune Wellness Solutions Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Prometheus Biosciences, Inc. | February 14, 2023 | 1,212,694 | 2.6% |
Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
SpringWorks Therapeutics, Inc. | February 14, 2023 | 2,617,691 | 4.2% |
Tarsus Pharmaceuticals, Inc. | February 14, 2023 | 1,296,416 | 4.9% |
Athenex, Inc. | February 02, 2023 | 15,532,467 | 9.9% |
Quotient LtdSold out | November 03, 2022 | 0 | 0.0% |
ANAPTYSBIO, INCSold out | February 15, 2022 | 0 | 0.0% |
BCLS Acquisition Corp. | February 15, 2022 | 1,000,000 | 6.7% |
BridgeBio Pharma, Inc. | February 15, 2022 | 7,128,755 | 4.8% |
COLLEGIUM PHARMACEUTICAL, INCSold out | February 15, 2022 | 0 | 0.0% |
Oncorus, Inc. | February 15, 2022 | 999,812 | 3.9% |
Outset Medical, Inc. | February 15, 2022 | 1,863,397 | 4.0% |
POINT Biopharma Global Inc. | February 15, 2022 | 1,193,995 | 1.3% |
Protara Therapeutics, Inc. | February 15, 2022 | 421,641 | 3.8% |
VYNE Therapeutics Inc. | February 15, 2022 | 2,425,604 | 4.5% |
Zymeworks Inc. | February 15, 2022 | 3,679,845 | 6.6% |
AGILE THERAPEUTICS INC | February 14, 2022 | 21,294,485 | 17.5% |
C4 Therapeutics, Inc. | February 14, 2022 | 2,208,913 | 4.5% |
DBV Technologies S.A.Sold out | February 14, 2022 | 0 | 0.0% |
Forte Biosciences, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
Frequency Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
Global Blood Therapeutics, Inc. | February 14, 2022 | 3,449,915 | 5.4% |
Neptune Wellness Solutions Inc. | February 14, 2022 | 10,055,521 | 6.0% |
Provention Bio, Inc. | February 14, 2022 | 948,481 | 1.5% |
ROCKET PHARMACEUTICALS, INC. | February 14, 2022 | 1,959,125 | 3.0% |
SCYNEXIS INCSold out | February 14, 2022 | 0 | 0.0% |
Travere Therapeutics, Inc. | February 14, 2022 | 1,845,555 | 3.0% |
Hancock Jaffe Laboratories, Inc. | September 17, 2021 | 954,248 | 9.9% |
CATABASIS PHARMACEUTICALS INC | June 25, 2021 | 7,687,185 | 9.9% |
Aquestive Therapeutics, Inc. | February 16, 2021 | 1,385,720 | 4.1% |
CytomX Therapeutics, Inc. | February 16, 2021 | 2,577,043 | 4.3% |
IDEAYA Biosciences, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
Kadmon Holdings, Inc. | February 16, 2021 | 16,240,747 | 9.4% |
Kodiak Sciences Inc. | February 16, 2021 | 751,533 | 1.5% |
MEI Pharma, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
Molecular Templates, Inc. | February 16, 2021 | 601,818 | 1.2% |
SC Health Corp | February 16, 2021 | 1,000,000 | 5.8% |
Therapeutics Acquisition Corp. | February 16, 2021 | 1,500,000 | 10.7% |
Urovant Sciences Ltd. | February 16, 2021 | 3,116,831 | 9.8% |
VAPOTHERM INCSold out | February 16, 2021 | 0 | 0.0% |
VYNE Therapeutics Inc. | February 16, 2021 | 27,095,819 | 14.3% |
ZOGENIX, INC.Sold out | February 16, 2021 | 0 | 0.0% |
Motus GI Holdings, Inc. | January 27, 2021 | 2,660,542 | 8.3% |
Menlo Therapeutics Inc. | June 11, 2020 | 22,876,410 | 14.0% |
ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2020 | 1,050,528 | 4.6% |
Foamix Pharmaceuticals Ltd. | February 14, 2020 | 11,203,881 | 18.3% |
LA JOLLA PHARMACEUTICAL COSold out | February 14, 2020 | 0 | 0.0% |
Marker Therapeutics, Inc.Sold out | February 14, 2020 | 0 | 0.0% |
NEUROCRINE BIOSCIENCES INC | February 14, 2020 | 3,612,554 | 3.9% |
Oncternal Therapeutics, Inc.Sold out | February 14, 2020 | 0 | 0.0% |
Protagonist Therapeutics, IncSold out | February 14, 2020 | 0 | 0.0% |
Retrophin, Inc. | February 14, 2020 | 2,890,608 | 6.7% |
ViewRay, Inc. | February 14, 2020 | 2,451,748 | 1.7% |
Dova Pharmaceuticals Inc.Sold out | November 18, 2019 | 0 | 0.0% |
Zymeworks Inc. | July 02, 2019 | 2,349,147 | 6.0% |
Alliqua BioMedical, Inc.Sold out | February 14, 2019 | 0 | 0.0% |
AVADEL PHARMACEUTICALS PLC | February 14, 2019 | 14,860 | 0.1% |
GTX INC /DE/ | February 14, 2019 | 1,443,333 | 6.0% |
HISTOGENICS CORPSold out | February 14, 2019 | 0 | 0.0% |
OncoMed Pharmaceuticals Inc | February 14, 2019 | 1,719,111 | 4.5% |
Sierra Oncology, Inc. | February 14, 2019 | 2,666,190 | 3.6% |
Corium International, Inc.Sold out | October 16, 2018 | 0 | 0.0% |
GTX INC /DE/ | May 29, 2018 | 1,501,501 | 6.7% |
ABEONA THERAPEUTICS INC. | February 14, 2018 | 1,319,298 | 2.8% |
Aclaris Therapeutics, Inc.Sold out | February 14, 2018 | 0 | 0.0% |
Adamis Pharmaceuticals CorpSold out | February 14, 2018 | 0 | 0.0% |
MGC DIAGNOSTICS CorpSold out | February 14, 2018 | 0 | 0.0% |
Neptune Technologies & Bioressources Inc. | February 14, 2018 | 8,374,015 | 10.6% |
Ocera Therapeutics, Inc.Sold out | February 14, 2018 | 0 | 0.0% |
pSivida Corp.Sold out | February 14, 2018 | 0 | 0.0% |
uniQure N.V. | February 14, 2018 | 1,047,950 | 3.4% |
Versartis, Inc. | February 14, 2018 | 1,488,160 | 4.2% |
Zynerba Pharmaceuticals, Inc.Sold out | February 14, 2018 | 0 | 0.0% |
ACELRX PHARMACEUTICALS INC | August 23, 2017 | 1,244,608 | 2.7% |
Alliqua BioMedical, Inc. | February 14, 2017 | 1,921,951 | 6.7% |
Arno Therapeutics, Inc | February 14, 2017 | 4,177,577 | 8.5% |
Ignyta, Inc. | February 14, 2017 | 6,584 | 0.0% |
LA JOLLA PHARMACEUTICAL CO | February 14, 2017 | 1,319,274 | 7.2% |
Lion Biotechnologies, Inc. | February 14, 2017 | 3,567,553 | 5.7% |
Quotient Ltd | February 14, 2017 | 2,854,486 | 9.7% |
GENVEC INC | February 16, 2016 | 615,844 | 3.6% |
Sarepta Therapeutics, Inc. | February 16, 2016 | 2,240,928 | 5.0% |
VBI VACCINES INC. | February 16, 2016 | 3,260,356 | 13.9% |
Xencor Inc | February 16, 2016 | 1,854,784 | 4.6% |
PLASMATECH BIOPHARMACEUTICALS INC | February 17, 2015 | 1,250,000 | 6.0% |
Aegerion Pharmaceuticals, Inc. | February 14, 2014 | 447,785 | 1.5% |
ATHERSYS, INC / NEW | February 14, 2014 | 1,700,887 | 2.4% |
HERON THERAPEUTICS, INC. /DE/ | February 14, 2014 | 35,248,555 | 7.5% |
INFINITY PHARMACEUTICALS, INC. | February 14, 2014 | 350,000 | 0.7% |
REPROS THERAPEUTICS INC. | March 21, 2013 | 812,560 | 4.4% |
CAPITAL SENIOR LIVING CORP | February 14, 2013 | 1,211,469 | 4.3% |
ICAGEN INC | February 10, 2012 | 350,000 | 4.0% |
SYNAGEVA BIOPHARMA CORPSold out | November 14, 2011 | 0 | 0.0% |
PHARMACYCLICS INC | February 14, 2011 | 2,757,523 | 4.6% |
UROPLASTY INC | February 14, 2011 | 1,044,738 | 5.1% |
EXACT SCIENCES CORP | October 22, 2010 | 1,789,289 | 4.4% |
PENWEST PHARMACEUTICALS COSold out | September 27, 2010 | 0 | 0.0% |
Hana Biosciences Inc | June 14, 2010 | 242,991 | 0.3% |
Endo Pharmaceuticals Solutions Inc.Sold out | August 05, 2009 | 0 | 0.0% |
XTL BIOPHARMACEUTICALS LTD | December 03, 2008 | 510,000 | 0.2% |
MACROCHEM CORP | November 24, 2008 | 1,615,058 | 3.5% |
OPTIMER PHARMACEUTICALS INC | October 23, 2008 | 1,443,729 | 4.9% |
MEDIVATION, INC. | September 11, 2008 | 1,495,167 | 5.0% |
NOVACEA INC | August 12, 2008 | 1,281,357 | 5.0% |
SPECTRUM PHARMACEUTICALS INC | August 12, 2008 | 312,696 | 1.0% |
MiddleBrook Pharmaceuticals, Inc. | June 23, 2008 | 2,458,102 | 4.4% |